The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...
The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.
Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...
A single hepatitis B injection set off a lasting immune response, and two patients reached a functional cure that held for ...
Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...
A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...
The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...
After treatment with bepirovirsen, however, 19% of patients achieved the strictly defined “functional cure” criteria. For the ...
9d
How a new drug shows promise as a 'functional cure' for Long Island's chronic hepatitis B patients
In about 20% of the drug's recipients, the virus remained undetectable for at least six months after all treatments were ...
The Canadian Press on MSN
Matsui advances to November ballot in reelection bid for California House seat
California Democratic Rep. Doris Matsui has advanced to the November ballot after facing a reelection challenge from a ...
Health and Me on MSN
Potential 'Functional Cure' For Hepatitis B: Trial Give Hope To Millions
The recent publication of a research paper on a drug trial has given hope to millions of patients with chronic hepatitis B ...
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results